SCHEMBL17682147

SCHEMBL17682147

Cn1cnc2c1c(=O)n(CC1CCC(O)(C(F)(F)F)CO1)c(=O)n2C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.48
▸ ADORA2B P29275 7/20 0.47
▸ GLA P06280 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ BCHE P06276 1/20 0.44
▸ TNF P01375 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ PDE4A P27815 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24611654 0.89 TRPA1 (0.56) TRPA1
SCHEMBL24611655 0.89 KMT2A (0.46) TRPA1ADORA2BBLMLMNACYP1A2
SCHEMBL19607680 0.86 KMT2A (0.44) TRPA1ADORA2BBLMLMNACYP1A2
SCHEMBL17682155 0.86 ADORA2B (0.50) ADORA2BGLABLMBCHETNF
SCHEMBL17682160 0.86 ADORA2B (0.50) ADORA2BGLABLMBCHETNF
SCHEMBL17682128 0.86 ADORA2B (0.50) ADORA2BGLABLMBCHETNF
SCHEMBL19601302 0.86 TRPA1 (0.51) TRPA1ADORA2BGLABLMBCHE
SCHEMBL19245931 0.84 ADORA2B (0.48) ADORA2BGLABLMBCHETNF
SCHEMBL19245902 0.84 ADORA2B (0.48) ADORA2BGLABLMBCHETNF
SCHEMBL17682151 0.84 ADORA2B (0.48) ADORA2BGLABLMBCHETNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233863-B Hydroxyl purine compound and application thereof 广东众生睿创生物科技有限公司 2022-10-25 — — CN disclosed
US-RE49128-E1 Hydroxyl purine compounds and applications thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2022-07-12 — — US disclosed
US-20170326149-A1 HYDROXYL PURINE COMPOUNDS AND APPLICATIONS THEREOF GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-11-16 — — US disclosed
EP-3205652-A1 HYDROXYL PURINE COMPOUNDS AND APPLICATIONS THEREOF Medshine Discovery Inc. (CN) 2017-08-16 — — EP disclosed
WO-2017071606-A1 MEDICAL USE OF HYDROXYL PURINE COMPOUND 南京明德新药研发股份有限公司 2017-05-04 — — WO disclosed
WO-2016054971-A1 HYDROXYL PURINE COMPOUNDS AND APPLICATIONS THEREOF 南京明德新药研发股份有限公司 2016-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170326149-A1 HYDROXYL PURINE COMPOUNDS AND APPLICATIONS THEREOF PNP, PDE2A, PDE7A TRPA1 3239/4885ADORA2B 116/4885GLA 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback